ABSA Annual Biosafety and Biosecurity Conference 2019

The ABSA Annual Biosafety and Biosecurity Conference will be held 15-20 November 2019 in Birmingham, Alabama.

Professional development courses will be November 15-17 and the conference presentations (platform/poster) will be November 18-20. Approximately 700 attendees representing a
broad spectrum of biosafety and biosecurity, pharmaceutical, biotechnology research, development, and clinical organizations are expected to attend. The conference draws national and international attendees from academic, commercial, research, and governmental sectors.

Sessions of interest highlighted by the Global Biodefense staff include:

Biosafety Critical Task Analysis as a Means to Mitigate Human Failure in a High-Containment Facility – Anna E. Lawton, BSc, The Pirbright Institute

The Challenge of Arthropod Biocontainment in the Non-model Organism World: Mosquitoes, Gene Drive, and Beyond – Zachary Adelman, PhD, Texas A&M University

Large-scale Decontamination and Decommissioning of a Vintage High-Containment Effluent Decontamination System (EDS), Planning Through Execution – Fahim Manzur, MS, Plum Island Animal Disease Center

Utility of the Incident Command System in Laboratory Emergency Management – Kaci VanDalen, MS, National Institutes of Health

Enhancement of Biosafety and Biosecurity in Tanzania Through Surveillance, Risk Assessment, and Identification of Select Agents in Bushmeat – Robab Katani, PhD, Penn State University

Risk Assessment and Facility Containment for Research with Gene Drive Arthropods – Sheryl Major, University of California-San Diego

Spores or Not Spores, ‘Tis the Question: Considerations for Biological Verification and Technical Feasibility of Room Fumigations – Daniel Kiimin, PhD, Basler & Hofmann AG

Implementation of WHO Global Action Plan III Containment Certification for US Poliovirus Type 2 Laboratories – Christy Ottendorfer, PhD, CDC

Biosafety and Biosecurity Measures in the Epidemiological Surveillance of Rabies Virus and Other Lyssaviruses in Mexico – Luis Alberto Ochoa Carrera, MS, Institute for Epidemiological Diagnosis and Reference (InDRE)

Microbial Aerosols in the Modern Microbiology Laboratory – Allan Bennett, MSc, Public Health England, Porton Down

Prion-like Proteins: Implementation of IBC Oversight – Susan Vleck, PhD, RBP(ABSA), Stanford University

//

Please visit the ABSA Annual Biosafety and Biosecurity Conference website for more information.